Rejoinder: Combining biomarkers to optimize patient treatment recommendations

Biometrics

Volumn 70, Issue 3, 2014, Pages 719-720

  Kang, Chaeryon ^a   Janes, Holly ^a   Huang, Ying ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS;

PATIENT TREATMENT;

TUMOR MARKER;

BIOMETRY; BLOOD; BREAST NEOPLASMS; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PROCEDURES; STATISTICAL ANALYSIS;

BIOMARKERS, TUMOR; BIOMETRY; BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84927694214     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/biom.12192     Document Type: Article

References (6)

1. Freund, Y. (2001). An adaptive version of the boost by majority algorithm. Machine Learning 43, 293-318.
2. Murphy, S. A. (2003). Optimal dynamic treatment regimes. Journal of the Royal Statistical Society, Series B 65, 331-355.
3. Zhang, B., Tsiatis, A., Laber, E., and Davidian, M. (2012). A robust method for estimating optimal treatment regimes. Biometrics 68, 1010-1018.
4. Zhang, B., Tsiatis, A. A., Davidian, M., Zhang, M., and Laber, E. (2012). Estimating optimal treatment regimes from a classification perspective. Stat 1, 103-114.
5. Zhao, Y., Kosorok, M. R., and Zeng, D. (2009). Reinforcement learning design for cancer clinical trials. Statistics in Medicine 28, 3294-3315.
6. Zhao, Y., Zeng, D., Rush, A. J., and Kosorok, M. R. (2012). Estimating individualized treatment rules using outcome weighted learning. Journal of the American Statistical Association 107, 1106-1118.